Literature DB >> 10752665

Multifocal demyelinative leukoencephalopathy associated with 5-fluorouracil and levamisole.

Z H Israel1, A Lossos, V Barak, D Soffer, T Siegal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10752665     DOI： 10.1080/028418600431085

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  4 in total

1.  Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study.

Authors:  Jérémy T Campillo; Céline Eiden; Michel Boussinesq; Sébastien D S Pion; Jean-Luc Faillie; Cédric B Chesnais
Journal:  Br J Clin Pharmacol       Date:  2021-09-15       Impact factor: 3.716

Review 2.  Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.

Authors:  Carla C P Verstappen; Jan J Heimans; Klaas Hoekman; Tjeerd J Postma
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Why, After Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?

Authors:  Summer F Acevedo
Journal:  Breast Cancer (Auckl)       Date:  2012-11-19

4.  Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.

Authors:  Ruolan Han; Yin M Yang; Joerg Dietrich; Anne Luebke; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2008-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.